Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

LUNAR: Pivotal, Randomized, Open-label Study of Tumor Treating Fields (TTFields) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure

NCT02973789 is registered in ClinicalTrials.gov with NovoCure GmbH as lead sponsor.

NCT NCT02973789
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02973789 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
LUNAR: Pivotal, Randomized, Open-label Study of Tumor Treating Fields (TTFields) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure
Lead sponsor
NovoCure GmbH
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2016
Completion date
October 9, 2024
Enrollment
291 (actual)
Sites
124

Conditions

As the registry lists them; a condition with its own page is linked.

nonsmall cell lung cancer, nsclc